Who
Ruth Alon
Director
Company insider
Files Form 4 as: Director, Silexion Therapeutics.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 9 Feb 2025
- Last trade
- 20 Feb 2026
- Last filed
- 23 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Feb 2026filed 23 Feb 2026 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,091 at $0.00 | filing |
| 20 Feb 2026filed 23 Feb 2026 | SLXN Silexion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,685 at $0.00 | filing |
| 20 Feb 2026filed 23 Feb 2026 | SLXN Silexion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,685 at $0.00 | filing |
| 20 Feb 2026filed 23 Feb 2026 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,091 at $0.00 | filing |
| 9 Feb 2025filed 31 Dec 2025 | SLXN Silexion Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —935 at $0.00 | filing |
| 9 Feb 2025filed 31 Dec 2025 | SLXN Silexion TherapeuticsBiotechnology | SEC FORM 4 Code A | —794 at $0.00 | filing |
News
Dear servants of the public, truth alone shall set you free, and not a censored cyber space!legallyindia.com · 1 Oct 2026
1 headline in the last 90 days name Ruth Alon; no company of theirs resolves to a name we track.
Sectors
No trade we could place in a sector.